SUBSCRIBE
SUBSCRIBE

Phase I

Drug Development
Biotech Bay Companies Fighting Against COVID-19
Biotech Bay, the bustling biotech industry around San Francisco in California, is home to many biopharma companies developing diagnostics, therapies, and vaccines to fight against coronavirus disease 2019 (COVID-19) and the virus that causes it, called SARS-CoV-2.
May 22, 2020
 · 
11 min read
 · 
Chelsea Weidman Burke, M.S.
BioForest
Clinical Catch-Up: May 18-22
Non-COVID-19 clinical trial updates are outweighing COVID-19 studies, particularly with the American Society of Clinical Oncology meeting coming up soon. Here’s a look.
May 22, 2020
 · 
9 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: May 22
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 22, 2020.
May 22, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
New researches on probable cure for HIV approachin
Drug Development
ImmunityBio’s Promising Preclinical HIV Drug is Moving into Phase I Trials
To learn more about ImmunityBio’s HIV drug candidate, BioSpace spoke to Dr. Whitney and Jeffrey Safrit, PhD, director of Cell-Mediated Therapies in Virology at NantKwest.
May 21, 2020
 · 
9 min read
 · 
Chelsea Weidman Burke
Policy
Biopharma Update on the Novel Coronavirus: May 21
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 21, 2020.
May 21, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: May 20
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 20, 2020.
May 20, 2020
 · 
6 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: May 19
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 19, 2020.
May 19, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
Moderna’s Preliminary Phase I COVID-19 Vaccine Data Shows Safety and Efficacy
Moderna released positive interim Phase I data from its clinical trial of mRNA-1273, its mRNA vaccine against SARS-CoV-2.
May 18, 2020
 · 
4 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: May 18
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 18, 2020.
May 18, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Bio NC
Clinical Catch-Up: May 11-15
Clinical trial updates not related to COVID-19 are on the upswing, partly because some companies are announcing trial information ahead of the upcoming American Society of Clinical Oncology virtual meeting being held at the end of the month. Here’s a look.
May 15, 2020
 · 
12 min read
 · 
Mark Terry
Load More
PRESS RELEASES
Drug Development
At278 Ultra-Concentrated Ultra-Rapid Acting Insulin Demonstrates Superiority in Phase i Clinical Trial in Overweight and Obese People With Type 2 Diabetes
May 20, 2024
 · 
7 min read
Drug Development
Karmanos Welcomes Wasif Saif, M.D., to Lead Phase 1 Clinical Trials
May 20, 2024
 · 
5 min read
Drug Development
Spago Nanomedical Provides an Update on Tumorad-01 - Trial Proceeds as Planned
May 20, 2024
 · 
3 min read
Drug Development
Recce Pharmaceuticals Doses First Participants in Next Cohort of Phase I/II Urinary Tract Infections and Urosepsis Rapid Infusion Clinical Trial
May 17, 2024
 · 
3 min read
Drug Development
Drug Farm Announces IND Clearance by U.S. FDA Enabling Phase 1b Initiation for ALPK1 Selective Kinase Inhibitor, DF-003 in ROSAH Syndrome Patients
May 17, 2024
 · 
2 min read
Drug Development
A2 Bio Announces First Patient Dosed in EVEREST-2 Phase 1 Clinical Trial of Novel Mesothelin Logic-Gated CAR T
May 16, 2024
 · 
3 min read
Drug Development
Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy’s Disease)
May 16, 2024
 · 
10 min read
Drug Development
Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-Monocyte
May 16, 2024
 · 
6 min read
Business
Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
May 16, 2024
 · 
9 min read
Drug Development
Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
May 16, 2024
 · 
9 min read
Drug Development
Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome
May 16, 2024
 · 
8 min read
Drug Development
Flamingo Therapeutics Announces First Patient Dosed in Investigator-Initiated Trial (IIT) Evaluating Danvatirsen in Phase 1 for AML/MDS Cancers
May 16, 2024
 · 
4 min read
Drug Development
Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer’s Disease
May 16, 2024
 · 
6 min read
Drug Development
South Rampart Pharma Publishes SRP-001’s Unique Pain Relief Mechanism and Phase 1 Trial Results in Scientific Reports
May 16, 2024
 · 
6 min read
Drug Development
Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)
May 16, 2024
 · 
20 min read
Drug Development
Genentech Reports Positive Phase Ib Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People With Obesity
May 16, 2024
 · 
4 min read
Drug Development
Bayer Starts Phase I Study With Novel Targeted Radionuclide Therapy 225Ac-PSMA-Trillium in Advanced Metastatic Prostate Cancer
May 15, 2024
 · 
5 min read
Drug Development
INIMMUNE ANNOUNCES SUCCESSFUL PHASE 1 CLINICAL RESULTS FOR DISEASE MODIFYING ALLERGY TREATMENT, INI-2004
May 15, 2024
 · 
3 min read
Drug Development
CASI Pharmaceuticals Receives FDA Clearance On The Investigational New Drug (IND) Application For CID-103 In Immune Thrombocytopenia (ITP)
May 15, 2024
 · 
5 min read
Drug Development
PharmaDrug’s Sairiyo Therapeutics Submits Clinical Trial Application for Phase 1 Study of Patented Reformulated Cepharanthine
May 15, 2024
 · 
7 min read
Load More